Posted in | News | Composites | Minerals | Fibers

CalciTech Announces Collaboration to Convert Waste Paper into Valuable Materials

CalciTech Ltd. (OTCBB:CLKTF) announces today that its wholly owned subsidiary CalciTech Synthetic Minerals Europe Ltd. (“CSME”) has signed a cooperation agreement with a group of partners including the Papiertechnische Stiftung (“PTS”), the German Paper Research Centre and Verein Deutscher Zementwerke (“VDZ”), the German Cement Works Association, together with two of the largest paper and cement companies in Europe.

The partners have agreed to study the optimisation of CalciTech’s process for converting the waste stream from recycled paper production into the industrially valuable materials Synthetic Calcium Carbonate (“SCC”) and Sustainable Metakaolin (“SMK”). By implementing this process the paper industry will save millions of Euros in waste disposal charges and taxes, recover Carbon Dioxide that would otherwise be lost to the environment and receive the SCC material that has more superior properties than the original mineral.

The cement industry is responsible for about 5 % of global CO2 emissions and is searching for ways to reduce its carbon footprint. Cement is made from clinker produced in energy intensive kilns. Substituting clinker is an important part of the industry’s carbon reduction plans. SMK has been shown to have good pozzolanic properties and its use as a substitute for clinker in Portland cement is being evaluated.

Due to the attractive environmental benefits and the innovative nature of the CalciTech process, it is expected that European government funding will be granted to support the project. The industrial partners will also contribute and will be beneficiaries when the process is implemented.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.